A rapid assay for determination of antiviral activity against human cytomegalovirus

Antiviral Research

Volumn 32, Issue 1, 1996, Pages 35-42

  Hippenmeyer, Paul J ^a   Dilworth, Vickie M ^a  

^a MONSANTO COMPANY   (United States)

Author keywords

Antiviral; Cytomegalovirus; RC256; Galactosidase

Indexed keywords

ACICLOVIR; BETA GALACTOSIDASE; GANCICLOVIR;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DRUG RESEARCH; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SCREENING; VIRUS INHIBITION; VIRUS RECOMBINANT;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5;

EID: 0030222284     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/0166-3542(95)00976-0     Document Type: Article

References (11)

1. Adler, J., Mitten, M., Norbeck, D., Marsh, K., Kern, E.R. and Clement, J. (1994) Efficacy of A-73209, a potent orally active agent against VZV and HSV infections. Antiviral Res. 23, 93-105.
2. Alford, C.A. and Britt, W.J. (1993) Cytomegalovirus. In: B. Roizman, R.J. Whitley and C. Lopez (Eds), The Human Herpesviruses, pp. 227-255. Raven Press, New York.
3. Freitas, V.R., Smee, D.F., Chernow, M., Boehme, R. and Matthews, T.R. (1985) Activity of 9-(1,3-dihydroxy-2-propoxymethyl)guanine compared with that of acyclovir against human, monkey and rodent cytomegaloviruses. Antimicrob. Agents Chemother. 28 (2), 240-245.
4. Gangopadhyay, N.N., Whitley, R.J. and Chatterjee, S. (1994) A rapid protein A binding radioimmunoassay for the evaluation of antiviral agents. J. Virol. Methods 48, 273-279.
5. Kern, E.R. (1991) Value of animal models to evaluate agents with potential activity against human cytomegalovirus. Transplant. Proc. 23 (Suppl. 3(3)), 152-155.
6. Langford, M.P., Weigent, D.A., Stanton, G.J. and Baron, S. (1981) Virus plaque-reduction assay for interferon: microplaque and regular macroplaque reduction assays. Methods Enzymol. 78, 339-346.
7. Lim. K. and Chae. C.-B. (1989) A simple assay for DNA transfection by incubation of the cells in culture dishes with substrates for β-galactosidase. Biotechniques 7 (6), 576-579.
8. Markham, A. and Faulds, D. (1994) Ganciclovir. An update of its therapeutic use in cytomegalovirus infection. Drugs 48 (3), 455-484.
9. Spaete, R.R. and Mocarski, E.S. (1987) Insertion and deletion mutagenesis of the human cytomegalovirus genome. Proc. Natl. Acad. Sci. USA 84, 7213-7217.
10. Tatarowicz, W.A., Lurain, N.S. and Thomson, K.D. (1991) In situ ELISA for the evaluation of antiviral compounds effective against human cytomegalovirus. J. Virol. Methods 35, 207-215.
11. Wagstaff, A.J. and Bryson, H.M. (1994) Foscarnet. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with viral infections. Drugs 48 (2), 199-226.